K. Akmalova

CYP2D6 phenotype and ABCB1 haplotypes are associated with antipsychotic safety in adolescents experiencing acute psychotic episodes

D. Ivashchenko, E. Grishina, D. Sychev, 2021, Drug metabolism and personalized therapy.

Associations of CYP2D6, ABCB1 2677G>T/A and 3435C>T with effectiveness and safety of pharmacotherapy for acute psychotic episodes in adolescents over 28 days

E. Grishina, D. Sychev, D. V. Ivaschenko, 2021, Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice.

CYP2D6 phenotype and ABCB1 haplotypes are associated with antipsychotic safety in adolescents experiencing acute psychotic episodes

D. Ivashchenko, E. Grishina, D. Sychev, 2021, Drug metabolism and personalized therapy.

Pharmacogenetics of antipsychotics in adolescents with acute psychotic episode during first 14 days after admission: effectiveness and safety evaluation

D. Ivashchenko, E. Grishina, D. Sychev, 2020, Drug metabolism and personalized therapy.

Analysis of associations between pharmacodynamic genetic factors and antipsychotics’ effectiveness and safety in adolescents with acute psychotic episodes taking antipsychotics during a 28-day follow-up

E. Grishina, D. Sychev, D. V. Ivaschenko, 2021, Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice.

Effect of polymorphisms in CYP3A4*22 (rs35599367) C>T, CYP3A5*3 (rs776746) A>G, ABCB1 (rs4148738) C>T and ABCB1 (rs1045642) C>T genes on apixaban anticoagulation: pilot study results

Федина, A. S. Osipov, K. Mirzaev, 2021, Meditsinskiy sovet = Medical Council.

Effect of CYP2D6*4, CYP2D6*10 polymorphisms on the safety of treatment with timolol maleate in patients with glaucoma

M. Zastrozhin, D. Ivashchenko, E. Grishina, 2022, Drug metabolism and personalized therapy.

Safety of dabigatran in patients with atrial fibrillation and chronic kidney disease: pharmacokinetic and pharmacogenetic aspects

D. Sychev, P. Bochkov, R. Shevchenko, 2020 .